Who is sponsoring NCT03895983?

NCT03895983 is sponsored by Assiut University.

What drugs are being tested in NCT03895983?

Interventions in NCT03895983: Percutaneous primary coronary intervention.

What condition does NCT03895983 study?

NCT03895983 studies ST Segment Elevation Myocardial Infarction.

Is NCT03895983 still recruiting?

NCT03895983 is currently status unknown. Last updated 29 March 2019.

Last reviewed 2019-03-29 · How we verify

NCT03895983: STresolution

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

ST Segment Resolution After Primary Percutaneous Coronary Intervention.

Status unknown Last updated 29 March 2019

What this trial tests

trial testing Percutaneous primary coronary intervention in ST Segment Elevation Myocardial Infarction in 270 participants. Status unknown.

Timeline

1 September 2019

Primary endpoint
1 September 2020

1 September 2021

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	270
Start date	1 September 2019
Primary completion	1 September 2020
Estimated completion	1 September 2021

Drugs / interventions tested

Percutaneous primary coronary intervention

Conditions studied

ST Segment Elevation Myocardial Infarction — all drugs for ST Segment Elevation Myocardial Infarction →

Sponsor

Assiut University

Who can join

Eligibility, any sex, with ST Segment Elevation Myocardial Infarction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare the ST segment resolution after primary percutaneous coronary intervention (PPCI) with and without thrombus aspiration in patients with ST segment elevation myocardial infarction as ST segment resolution is the best indicator for the prediction of the outcome and MACE

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for ST Segment Elevation Myocardial Infarction

Currently open trials in the same condition.

NCT03787745 — Ischemic Postconditioning in STEMI Patients Treated With Primary PCI · NA · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03895983 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 29 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03895983.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing